Subtype
Malignant Hepatobiliary Neoplasm
CI-CAN-00001136Explore in graph →
1,159 active trials17 approved drugs42 evidence items
- NCIt
- C8609
Loading cancer entity…
Subtype
CI-CAN-00001136Explore in graph →
Clinical trials
5,025 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (560)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05705791 | Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma(HOLMBRAVE) | terminated | N/A | 10 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT05718882 | Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC | terminated | N/A | 5 | RenJi HospitalOTHER | 1 |
| Apr 30, 2026 |
| clinicaltrials |
| NCT02439008 | Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response | terminated | N/A | 28 | Centre Oscar LambretOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT04258566 | Electromagnetic Tracking and Optical Imaging With ICG for Hepatic Biopsies | terminated | N/A | 7 | National Institutes of Health Clinical Center (CC)NIH | 1 | Feb 2, 2026 | clinicaltrials |
| NCT02881554 | Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery | terminated | N/A | 41 | University of WashingtonOTHER | 1 | Oct 29, 2025 | clinicaltrials |
| NCT06302400 | Individualized Dosimetry for Holmium-166 Radioembolization in Patients With Unresectable Hepatocellular Carcinoma(RHEPaiR) | terminated | N/A | 4 | Imperial College LondonOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT05582018 | Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures(PANORAMA) | terminated | N/A | 4 | Techsomed Medical Technologies LTDINDUSTRY | 1 | Sep 15, 2025 | clinicaltrials |
| NCT05451862 | Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma.(HOMIE-166) | terminated | N/A | 6 | Terumo Europe N.V.INDUSTRY | 1 | Aug 26, 2025 | clinicaltrials |
| NCT04520906 | To Evaluate the Safety and Efficacy of Microwave Ablation Therapy in Patients With Primary Liver Cancer | terminated | N/A | 61 | Suzhou Hengruihongyuan Medical Technology Co. LTDINDUSTRY | 1 | Jul 1, 2025 | clinicaltrials |
| NCT03534141 | Mild Hypothermia and Acute Kidney Injury in Liver Transplantation(MHALT) | terminated | N/A | 175 | University of California, San FranciscoOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT03889093 | Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune System | terminated | N/A | 14 | University of MinnesotaOTHER | 1 | Mar 24, 2025 | clinicaltrials |
| NCT03812289 | Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer | terminated | N/A | 9 | OHSU Knight Cancer InstituteOTHER | 1 | Mar 7, 2025 | clinicaltrials |
| NCT05845502 | Single-arm, Open-label Clinical Study of SZ003 in the Treatment of Advanced Hepatocellular Carcinoma | terminated | N/A | 8 | Shantou University Medical CollegeOTHER | 1 | Jan 29, 2025 | clinicaltrials |
| NCT04066660 | Study of Oligo-Fucoidan in Advanced Hepatocellular Carcinoma (HCC) | terminated | N/A | 87 | Hi-Q Marine Biotech International, Ltd.INDUSTRY | 1 | Jan 13, 2025 | clinicaltrials |
| NCT02512692 | Gemcitabine-Cisplatin-90Y TARE for Unresectable Intrahepatic Cholangiocarcinoma | terminated | N/A | 6 | Medical University of South CarolinaOTHER | 1 | Nov 18, 2024 | clinicaltrials |
| NCT04923672 | Exercise Preconditioning with Cancer Surgeries(ExPre 01) | terminated | N/A | 10 | University of VirginiaOTHER | 1 | Oct 16, 2024 | clinicaltrials |
| NCT02649868 | LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors | terminated | N/A | 19 | National Institutes of Health Clinical Center (CC)NIH | 1 | Jul 11, 2024 | clinicaltrials |
| NCT02722616 | Ultrasound Monitoring of Abdominal Soft Tissue | terminated | N/A | 2 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 18, 2024 | clinicaltrials |
| NCT03753789 | Ablation Confirmation Study | terminated | N/A | 46 | Ethicon, Inc.INDUSTRY | 1 | Jan 5, 2024 | clinicaltrials |
| NCT02802124 | Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular Carcinoma | terminated | N/A | 30 | Shanghai Proton and Heavy Ion CenterOTHER | 1 | Dec 7, 2023 | clinicaltrials |
| NCT04235660 | Y90 Radiation Segmentectomy vs SBRT for HCC(SBRT vs Y90) | terminated | N/A | 2 | Indiana UniversityOTHER | 1 | Oct 25, 2023 | clinicaltrials |
| NCT02847468 | Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib(PREMETHEP) | terminated | N/A | 61 | Centre Georges Francois LeclercOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT03662841 | Ablative Chemoembolization for Unresectable and Large Hepatocellular Carcinoma | terminated | N/A | 11 | Chinese University of Hong KongOTHER | 1 | May 3, 2023 | clinicaltrials |
| NCT03808766 | A Study on the Angioarchitecture of Hepatocellular Carcinoma | terminated | N/A | 32 | Chinese University of Hong KongOTHER | 1 | May 3, 2023 | clinicaltrials |
| NCT04649671 | The Effect of Mobile Health-based Exercise on Hepatocellular Carcinoma Patients With Insulin Resistance | terminated | N/A | 15 | Samsung Medical CenterOTHER | 1 | Mar 6, 2023 | clinicaltrials |
| NCT04077372 | Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers | terminated | N/A | 12 | Stanford UniversityOTHER | 1 | Jan 27, 2023 | clinicaltrials |
| NCT01167374 | Carbon Ion Radiotherapy for Hepatocellular Carcinoma(PROMETHEUS-01) | terminated | N/A | 21 | University Hospital HeidelbergOTHER | 1 | Nov 3, 2022 | clinicaltrials |
| NCT02446925 | Surefire Catheter Versus Standard End-hole Microcatheter: A Pilot Study | terminated | N/A | 8 | Wright State UniversityOTHER | 0 | Jul 28, 2022 | clinicaltrials |
| NCT03402607 | Trial Comparing PLA to HIGRT (PROVE-HCC)(PROVE-HCC) | terminated | N/A | 12 | Duke UniversityOTHER | 1 | Jul 8, 2022 | clinicaltrials |
| NCT03956940 | Analysis of cfDNA in Patients With Hepatocarcinoma and Treated by Sorafenib or Regorafenib(HELP) | terminated | N/A | 18 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT02704130 | TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma | terminated | N/A | 8 | Wake Forest University Health SciencesOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT03852836 | Evaluation of MRI Sequences for Ultra-rapid Acquisition of Bile Ducts Images(BiliFast) | terminated | N/A | 53 | IHU StrasbourgOTHER | 1 | Apr 6, 2022 | clinicaltrials |
| NCT03979547 | EXALT: EXercise Attenuates Liver Tumors Trial(EXALT) | terminated | N/A | 3 | Milton S. Hershey Medical CenterOTHER | 1 | Mar 9, 2022 | clinicaltrials |
| NCT01141478 | Proton Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With HCC Exceeding San Francisco Criteria(HCC) | terminated | N/A | 8 | Loma Linda UniversityOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT00503867 | SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma | terminated | N/A | 10 | Sirtex MedicalINDUSTRY | 1 | Dec 10, 2020 | clinicaltrials |
| NCT02966223 | A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver | terminated | N/A | 20 | Indiana UniversityOTHER | 1 | Sep 25, 2020 | clinicaltrials |
| NCT01486134 | Major RF Ablations of Hepatomas Under MR Thermometry Monitoring(ARMTICH) | terminated | N/A | 15 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 13, 2020 | clinicaltrials |
| NCT03172832 | A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors(INTERCPT) | terminated | N/A | 13 | Medical University of South CarolinaOTHER | 1 | Mar 25, 2020 | clinicaltrials |
| NCT03211169 | Comparison Bile Duct Brushings, Cholangioscopy-Directed Biopsies and Pediatric Forceps Biopsies in Biliary Strictures | terminated | N/A | 12 | Stanford UniversityOTHER | 1 | Nov 8, 2019 | clinicaltrials |
| NCT02323360 | A Trial on SBRT After Incomplete TAE or TACE Versus Exclusive TAE or TACE For Treatment of Inoperable HCC | terminated | N/A | 41 | Istituto Clinico HumanitasOTHER | 1 | Oct 25, 2019 | clinicaltrials |
| NCT02147301 | TACE Using Doxorubicin-eluting Beads for Patients With HCC and Marginal Hepatic Reserve | terminated | N/A | 17 | University of California, San FranciscoOTHER | 1 | Sep 10, 2019 | clinicaltrials |
| NCT01817205 | Combined Chemoembolization and Systemic Hyperthermia for Unresectable Hepatocellular Carcinoma | terminated | N/A | 8 | Chinese University of Hong KongOTHER | 1 | Aug 30, 2019 | clinicaltrials |
| NCT01408043 | Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma | terminated | N/A | 25 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 14, 2019 | clinicaltrials |
| NCT01290523 | Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma | terminated | N/A | 14 | University of California, San FranciscoOTHER | 1 | May 13, 2019 | clinicaltrials |
| NCT02748304 | Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma | terminated | N/A | 52 | Fudan UniversityOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT02204124 | Whipple Procedure: Standard of Care vs. Thunderbeat | terminated | N/A | 44 | Washington University School of MedicineOTHER | 1 | Sep 19, 2018 | clinicaltrials |
| NCT02057874 | 3-Tesla MRI Response to TACE in HCC (Liver Cancer) | terminated | N/A | 2 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 11, 2018 | clinicaltrials |
| NCT02748161 | DEB-TACE for Hepatocellular Carcinoma(QED) | terminated | N/A | 170 | Surefire Medical, Inc.INDUSTRY | 1 | Jun 21, 2018 | clinicaltrials |
| NCT01259024 | The LC Bead Trial; Transarterial Chemoembolization of Hepatocellular Carcinoma (HCC)With a Drug-eluting Bead | terminated | N/A | 1 | Washington University School of MedicineOTHER | 1 | May 15, 2018 | clinicaltrials |
| NCT01721174 | Endoscopic Biliary Radiofrequency Ablation of Malignant Distal Common Bile Duct Strictures | terminated | N/A | 42 | Chinese University of Hong KongOTHER | 1 | Jan 26, 2018 | clinicaltrials |
Data updated 22 days agoSource updated Jul 8, 2026source: clinicaltrials